OGN:NYSE
Organon & Co
$13.71
arrow_upward
+0.07%(+0.010) 1D
$13.71
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 1, 4:00:07 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
$13.71
High
$13.74
Low
$13.71
Mkt. cap
3.60B
Avg. vol.
2.87M
Volume
2.10M
Dividend
0.58%
Quarterly dividend
$0.02
Ex-dividend date
Aug 14, 2026
P/E ratio
17.56
52-wk high
$13.78
52-wk low
$5.69
EPS
$0.78
Beta
1.52
Shares outstanding
262.61M
No. of employees
10K
Open
$13.71
High
$13.74
Low
$13.71
Mkt. cap
3.60B
Avg. vol.
2.87M
Volume
2.10M
Dividend
0.58%
Quarterly dividend
$0.02
Ex-dividend date
Aug 14, 2026
P/E ratio
17.56
52-wk high
$13.78
52-wk low
$5.69
EPS
$0.78
Beta
1.52
Shares outstanding
262.61M
No. of employees
10K
News stories
From web sources and news partners
Stock Titan
·
8 hours ago
One of the first large-scale real-world analyses of an eczema cream will be shown
Yahoo Finance
·
17 hours ago
Organon & Co. (OGN) Stock Forecasts
Simply Wall St
·
1 day ago
What Comes Next For Organon (OGN) After A 30% Gain
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10K
Founded1923
HeadquartersJersey City, New Jersey, United States
SectorPharmaceutical industry
Websiteorganon.com